Related Experiment Video
Updated: Jun 8, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials
Robert L Comis1, Jon D Miller, Diane D Colaizzi
1Coalition of Cancer Cooperative Groups, Philadelphia, PA; and Michigan State University, East Lansing, MI.
Abstract:
The development of new cancer therapies requires additional, and more complex, clinical trials. But only approximately 3% to 5% of adult cancer patients participate in cancer clinical trials. This study seeks to identify and understand the attitudes of the public and cancer survivors toward health-related decisions and cancer clinical trials to identify the key factors that must be addressed to increase that percentage.
Insights
Public and cancer survivor attitudes toward clinical trials are key to increasing participation. Understanding these views can help improve access to novel cancer therapies and advance cancer research.
Area of Science:
- Oncology
- Clinical Trials
- Public Health
Background:
- Developing novel cancer therapies necessitates complex clinical trials.
- Current adult cancer patient participation in clinical trials remains low, between 3% and 5%.
Purpose of the Study:
- To identify and understand public and cancer survivor attitudes towards health-related decisions.
- To determine key factors influencing participation in cancer clinical trials.
Main Methods:
- Qualitative study exploring patient and public perceptions.
- Analysis of attitudes towards health decisions and clinical trial enrollment.
Main Results:
- Low participation rates in cancer clinical trials are linked to specific public and survivor attitudes.
- Key factors influencing decision-making for trial participation were identified.
Conclusions:
- Addressing identified attitudes and barriers is crucial for increasing cancer clinical trial enrollment.
- Enhancing patient and public understanding can improve access to innovative cancer treatments.
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Cancer Survival Analysis
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...